Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.

J. Smyth,S. Gundersen,J. Renard,H. Pinedo
European Journal of Cancer and Clinical Oncology
Abstract:
What problem does this paper attempt to address?